Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. (Q38172849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Magali Castells

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jean-Pierre Delord

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Bettina Couderc

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

1 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

Cancer and Metastasis Reviews

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

17-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24357056%20AND%20SRC:MED&resulttype=core&format=json

Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Rethinking ovarian cancer: recommendations for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Increased incidence of brain metastases in BRCA1-related ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Gastric metastasis from ovarian carcinoma: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophospholipids activate ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophospholipids increase interleukin-8 expression in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

SPARC ameliorates ovarian cancer-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Role of the 18:1 lysophosphatidic acid-ovarian cancer immunoreactive antigen domain containing 1 (OCIAD1)-integrin axis in generating late-stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian cancer cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The paradigm of IL-6: from basic science to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The role of cytokines in both the normal and malignant ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Characterization and proteomic analysis of ovarian cancer-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Interaction and uptake of exosomes by ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Cell adhesion in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Normalization of the ovarian cancer microenvironment by SPARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The PI3K/Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Site-dependent angiogenic cytokine production in human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Functional significance of VEGFR-2 on ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Up-regulation of stromal versican expression in advanced stage serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

EphA2 overexpression is associated with angiogenesis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Molecular determinants of ovarian cancer plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Targeting angiogenesis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Incorporation of bevacizumab in the primary treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

A phase 3 trial of bevacizumab in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Cancer associated fibroblasts (CAFs) in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

The effect of endostatin mediated by human mesenchymal stem cells on ovarian cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Obesity and ovarian cancer survival: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Body size and risk of epithelial ovarian and related cancers: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Induction and effector functions of T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Tumor-associated neutrophils: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Bevacizumab as front-line treatment for newly diagnosed epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Effect of Epidermal Growth Factor Receptor Expression Level on Survival in Patients with Epithelial Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2

Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9456-2